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Background: Restriction-modification (RM) systems appear to play key roles in modulating gene flow among
bacteria and archaea. Because the restriction endonuclease (REase) is potentially lethal to unmethylated new host
cells, regulation to ensure pre-expression of the protective DNA methyltransferase (MTase) is essential to the spread
of RM genes. This is particularly true for Type IIP RM systems, in which the REase and MTase are separate,
independently-active proteins. A substantial subset of Type IIP RM systems are controlled by an activator-repressor
called C protein. In these systems, C controls the promoter for its own gene, and for the downstream REase gene
that lacks its own promoter. Thus MTase is expressed immediately after the RM genes enter a new cell, while
expression of REase is delayed until sufficient C protein accumulates. To study the variation in and evolution of this
regulatory mechanism, we searched for RM systems closely related to the well-studied C protein-dependent PvuII
RM system. Unexpectedly, among those found were several in which the C protein and REase genes were fused.
Results: The gene for CR.NsoJS138I fusion protein (nsoJS138ICR, from the bacterium Niabella soli) was cloned, and
the fusion protein produced and partially purified. Western blots provided no evidence that, under the conditions
tested, anything other than full-length fusion protein is produced. This protein had REase activity in vitro and, as
expected from the sequence similarity, its specificity was indistinguishable from that for PvuII REase, though the
optimal reaction conditions were different. Furthermore, the fusion was active as a C protein, as revealed by in vivo
activation of a lacZ reporter fusion to the promoter region for the nsoJS138ICR gene.
Conclusions: Fusions between C proteins and REases have not previously been characterized, though other fusions
have (such as between REases and MTases). These results reinforce the evidence for impressive modularity among
RM system proteins, and raise important questions about the implications of the C-REase fusions on expression
kinetics of these RM systems.
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Regulatory evolutionBackground
Restriction-modification (RM) systems appear to play
key roles in modulating gene flow among bacteria and
archaea. This includes not only defense against bacte-
riophages [1,2], but also negative and positive modula-
tion of interspecies gene transfers [3,4]. Because the* Correspondence: Robert.Blumenthal@utoledo.edu
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distribution, and reproduction in any mediumrestriction endonuclease (REase) is potentially lethal to
unmethylated new host cells [5,6], regulation to ensure
pre-expression of the protective DNA methyltransferase
(MTase) is essential to the spread of RM genes. This is par-
ticularly true for Type IIP RM systems, in which the REase
and MTase are separate, independently-active proteins [7].
A substantial subset of Type IIP RM systems are controlled
by an activator-repressor called C protein [8,9]. In these
systems, C controls the promoter for its own gene, and for
the downstream REase gene that lacks its own promoter
[10] (Figure 1A). In tested C-protein-dependent RM sys-
tems, including PvuII, the C protein both activates andd Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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Figure 1 Genetic maps and putative regulatory DNA sequences for RM systems containing R.PvuII orthologs. A. Three classes of RM
systems containing R.PvuII orthologs. Top is PvuII itself, and systems at the right share its basic layout. In the middle is NsoJ138I, exemplifying
systems with a fused C-REase protein. The systems at right share this layout, though in Asp and Gsp the MTase gene is in the opposite
orientation. At the bottom is a streptococcal system (“Ssp”) that lacks a C gene, as does a system from Lachnospiraceae (“Lba”). B. Putative
regulatory regions. The ATG at bottom right is the initiation codon for the C gene (except for Lba and Ssp, which have no C gene so the REase
initiator is shown). The names of systems with fused C-REase genes are in bold; the subset from cyanobacteria are shaded (sequences shared by
these three are also shaded). Most systems have the MTase gene divergently oriented from the C gene, and the initiator reverse complement is
indicated in bold (CAT); the MTase initiator for Pvu is very close to that for the C gene (overlapping the downstream-most C box, and
underlined). In the Asp, Gsp, Ssp and Lba systems the MTase and C (REase) are convergent. Rectangles indicate symmetry elements from C boxes
(based on PvuII), with matches in other systems indicated in bold. Lba and Ssp, which lack a C gene and (presumably) C boxes, are shown for
comparison. Species sources are: Pvu (Proteus vulgaris), Esp (Escherichia spp. TW09308), Spt (Salmonella enterica Paratyphi A), Sba (Salmonella
enterica Bareilly), Pwa (Pectobacterium wasabei), Xsp (Xanthomonas spp.), Vei (Verminephrobacter eiseniae), Bce (Bacteroides cellulosilyticus), Mru
(Meiothermus ruber), Nso (Niabella soli), Oni (Oscillatoria nigro-viridis), Asp (Anabaena spp.), Gsp (Gloeocapsa spp.), Lba (Lachnospiraceae bacterium),
and Ssp (Streptococcus spp. GMD1S). GenBank accession numbers are in Methods.
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process has been studied structurally [15-17] and by math-
ematical modelling [18,19]. The C protein operators, called
C boxes, have recognizable sequences with symmetrical ele-
ments upstream of the C ORFs [8,10,20,21]. Thus MTase is
expressed immediately after the RM genes enter a new cell,
while expression of REase is delayed until sufficient C pro-
tein accumulates [22].To study the variation in and evolution of this regula-
tory mechanism, we searched for RM systems closely re-
lated to the well-studied C protein-dependent PvuII RM
system. The PvuII system was discovered and cloned
nearly three decades ago [23,24], yielded the discovery of
C proteins [9], and has been subject to structural
[25-27], evolutionary [28], and detailed regulatory stud-
ies [10,19,21,22,29,30]. PvuII thus represented a good
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protein-dependent regulatory mechanism.
Unexpectedly, among the PvuII-orthologous RM sys-
tems that we found were several in which the C protein
and REase genes were translationally fused. One of
these, selected for further study, was the NsoJS138I RM
system from the bacterium Niabella soli. We report here
that the NsoJS138I fused protein is produced, and is
functional for both C protein and REase activities.
Results
Identification of RM systems containing genes
orthologous to pvuIIR
We began our studies on evolution and variation of RM
regulation by identifying RM systems that contained genes
orthologous to the PvuII REase gene, pvuIIR. We have
identified such RM systems in the past [28], and the use of
the REase gene for such searches yielded the best results, in
terms of returning the most clearly orthologous systems.
This is because the C proteins have substantial sequence
identities even when coming from unrelated RM systems
[8,9], and the MTases similarly have well-conserved se-
quence motifs [31,32]. However, sequence and structural
similarities among REases are quite limited [33-35].
We used the amino acid sequence of R.PvuII (gi
135242) as the search seed (initial query), and examined
all available bacterial and archaeal genome sequences
(complete and shotgun) using the program TBlastN
[36]. The aligned REase sequences are shown in Figure
S1 (note: all supplementary figures are in Additional
file 1), and an unrooted tree indicates their relatedness
in Additional file 1: Figure S2. The regulatory regions
from these systems are shown in Figure 1B. Of ten RM
systems identified (including two from a previous study
[28], and excluding identical systems), nine were like
PvuII in that they also contained a C protein gene and
had the MTase gene divergently oriented from that of C
and the REase (Figure 1A).
Interestingly, we found a PvuII-orthologous system
that lacked the C protein gene altogether, in the Gram-
positive Clostridium-related family Lachnospiraceae. In
this RM system, the MTase and REase genes are conver-
gent rather than divergent, though there are numerous
examples of C-regulated RM systems with convergent
orientations [9,37]. Not surprisingly, there is no signifi-
cant sign of C-protein binding sites (C boxes) in the
Lachnospira sequence (Figure 1B). Using this REase aa
sequence as a search seed revealed a closely-related RM
system lacking a C gene in the Gram-positive genus
Streptococcus (Figure 1A). This is also shown in
Figure 1B, and also lacks obvious C boxes. Its regulatory
region exhibits no significant similarity to the one up-
stream of the Lachnospira REase gene (bottom lines in
Figure 1B), even though the Lachnospira and StreptococcusREase amino acid sequences are closely related (Additional
file 1: Figure S2). It could be informative, with respect to
our understanding of how the regulation of these RM sys-
tems evolves, to know how these two systems are con-
trolled and whether they use the same mechanisms.
To our surprise we also found that, in two of the other
PvuII-orthologous RM systems, the C protein and REase
genes are translationally fused (Figure 1A). Furthermore,
using these fused genes as search seeds, we identified
three additional RM systems. The set of five R.PvuII-
orthologous fused genes, along with the two unfused
PvuII proteins for comparison, is shown in Figure 2. The
C-orthologous portions of these five proteins range from
35-54% identity to C.PvuII (Figure 2 lower right). The
REase portions of C-REase fusions range from 50-69%
identity to R.PvuII, and are not all phylogenetically clus-
tered, suggesting that fusion may have occurred more
than once (Additional file 1: Figure S2). Specifically, the
three cyanobacterial REase fusions very probably oc-
curred separately from the Mru and Nso fusions, which
in turn may or may not have been independent from
one another.
These fused systems come from diverse bacteria: three
are from genera in the phylum Cyanobacteria (Anabaena,
Gloeocapsa and Oscillatoria), one is from the phylum
Deinococcus-Thermus (Meiothermus), and one from the
phylum Bacteroidetes (Niabella). The three cyanobacterial
fusion proteins have a ~25 aa linker region between the C
protein and REase regions, that is not present in the
Meiothermus or Niabella fusions; among the conserved
positions present in all three of the cyanobacterial linker re-
gions are two Glu, three Thr, and three Pro. The three
cyanobacterial fused systems also share features in their
regulatory regions, including a putative C box well up-
stream of the usual position (bold text in shaded region,
middle rows of Figure 1B). It is possible that this increased
C box spacing is needed to accommodate DNA complexes
with the fused proteins.
The RM database REBASE [38] includes regularly-
updated automated searches for REases among DNA
sequences. One of the fusions we found was originally
noted in REBASE (M. ruber, Mru1279I, 10-Mar-2010/
26-May-2013), and the rest were detected while this
work was in progress but not notated as involving C-
REase fusions (A. species, Asp90I, 17-Nov-2012; G. spe-
cies, Gsp7428I, 23-Dec-2012; N. soli, NsoJS138I, 10-
Apr-2013; O. nigro-viridis, Oni7112I, 20-Dec-2012).
We have uniformly adopted the REBASE nomenclature
for these RM systems.
Isolation of genes for fused RM systems and their
REase activity
The central question regarding these C-REase fusions is
whether or not they are active. There are numerous
Figure 2 Alignment of CR fusion proteins orthologous to C.PvuII and R.PvuII. The PvuII system (top line) is unfused, and shown for
comparison. Fully conserved positions or those conserved in 5/6 systems are shaded, and known functional regions (in PvuII) are in bold font
(transcriptional activation, recognition helix of the helix-turn-helix motif, dimerization interfaces, Mg++-coordinating residues for REase catalysis
(cat), and recognition of the methylated (CH3) base to prevent cleavage. Species sources are as described in the Figure 1 legend. At the lower
right, the numbers indicate % amino acid identity (“Ident”) or similarity (“Pos”) for each RM system C or REase (“R”) portion to the corresponding
PvuII polypeptide.
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comparisons, that do not produce catalytically active
proteins [28,39]. We focused on two of the fused RM
systems, isolating the Meiothermus ruber Mru1279I
genes by amplification from genomic DNA (not shown),
and having the Niabella soli NsoJS138I genes synthe-
sized. We were unable to detect REase or MTase activity
from the sequence-confirmed M. ruber clones (not
shown), possibly due to poor expression in E. coli and/or
improper folding of the protein at the lower E. coli
growth temperature (37°C), though cell extracts were
tested at the optimum for M. ruber growth (60°C) [40].
In contrast, extracts from E. coli cultures carrying the
N. soli genes gave obvious REase activity that indicated a
specificity indistinguishable from that of PvuII REase.
This was expected, given the sequence similarity
(Figure 2). However, the NsoJS138I C-REase fusion
exhibited much more stringent activity requirements
than R.PvuII when they were tested at four temperatures
in each of four buffers (Figures 3, Additional file 1:
Figures S3, and S4). Specifically, R.PvuII was active in
15/16 tested conditions, while the fusion was active in 5/
16. In particular, NsoJS138I was inactive at 27 and 42°Cin all tested buffers, while PvuII was active in all buffers
at those two temperatures. NsoJS138I was active in three
buffers at 32° and two buffers at 37°C (Additional file 1:
Figures S3 and S4), and serial dilution indicated that,
at 32°C, NsoJS138I was most active in NEBuffer 3
(Additional file 1: Figure S4). These experiments used 10
u of PvuII from a commercial supplier; this is equivalent
to ~20 ng of PvuII REase protein [41]. In comparison,
2.4 μg of NsoJS138ICR protein was used (~ 120× as much).
Differences from R.PvuII could be due to the presence of
the fused C portion at the amino ends of each subunit, to
the sequence differences between the PvuII and NsoJS138I
REase portions (Figure 2), or a combination of the two fac-
tors. The C-terminal His tag might also play a role, though
it has little effect on R.PvuII.
Production of CR.NsoJ138I as a fusion protein
The sequence of the NsoJ138I C-REase clearly indicates
that a single fused polypeptide should be produced.
However, it is possible that translational frameshifting
[42] could result in the production of free C protein (as
that portion is amino-proximal to the REase portion), or
that proteolytic processing could result in both free C
Figure 3 Assessment of REase activity in CR.NsoJS138I. A comparison was made between commercial R.PvuII and CR.NsoJS138I. Enzymes
were incubated for 1h with DNA from bacteriophage λ. Four different reaction buffers were used, and in each buffer four temperatures were
used. Reactions were resolved on agarose-TBE gels containing ethidium bromide (see Methods for details). Inset: Left-to-right: markers, uncut
pUC19, pUC19 cut with CR.NsoJS138I or PvuII at 37°, pUC19 cut with CR.NsoJS138I at 30°.
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frameshifting is suggested by two features of the DNA
sequence in the junction region (Figure 4A): one is a
short sequence that has been associated with −1 trans-
lational frameshifts [43], and the other is a nearby stop
codon in the −1 reading frame.
To test for these possibilities, we added a His6 tag to the
amino or carboxyl end of the fusion protein, expressed the
tagged proteins from a strong inducible promoter, partially
purified cell extracts on affinity columns, and resolved the
column eluates on SDS-polyacrylamide gels. Figure 4B
shows the Coomassie stained gels next to western blots
probed with anti-His6 antiserum, while Additional file 1:
Figure S5 shows the amino-tagged protein isolated in the
presence of protease inhibitor PMSF. Translational
frameshifting would result in a ~9 kDa polypeptide in the
extracts with amino-tagged fusion (the carboxyl-tagged fu-
sion would only yield smaller protein in the case of proteo-
lytic cleavage), and we see no evidence for that product.
We cannot rule out the possibility that frameshifting occurs
in the native host (N. soli), or in E. coli under different
growth conditions. Nevertheless, the protein preparation
used for the assays shown in Figure 3 was partially purified
via a His6 affinity tag at the carboxyl end, and together with
the results shown in the lower right panel of Figure 4B
strongly suggest that the intact fusion protein is catalytically
active.
In vivo test of CR.NsoJ138I for C protein activity
Based on comparison to PvuII and other previously-
studied C-dependent RM systems, we identifiedcandidate C boxes upstream of the C-REase fusions, in-
cluding NsoJ138I (Figure 1B). We also examined this re-
gion of the NsoJ138I sequence for putative bacterial
promoters [44-46], with a candidate (boxed in Figure 5B)
selected based on both its sequence and its position rela-
tive to the putative C boxes. A 161 bp sequence, includ-
ing the putative C boxes and promoter (Figure 5B), was
cloned upstream of a reporterless lacZ gene, in an E. coli
strain that also carried ΔlacZ and the nsoJ138ICR gene
under control of T7 RNA polymerase (Figure 5A). In
this strain, IPTG induction leads to production of T7
RNA polymerase, which results in production of CR.
NsoJ138I (Figure 4B). If CR.NsoJ138I activates the puta-
tive promoter region, β-galactosidase (LacZ) activity will
be increased. We carried out two independent experi-
ments to test this. First, IPTG was added to growing
cultures with or without the promoter-lacZ fusion
plasmid, and samples taken over time showed a clear
induction (Figure 5C). We also grew cultures under
conditions approximating steady-state, where the
IPTG (when present) was in the culture medium for at
least 10 generations, and the slope of the activity vs.
culture OD plot is a sensitive measure of expression.
As shown in Figure 5D, we observed a 23-fold increase
in LacZ activity in response to production of CR.
NsoJ138I. This presumably under-represents the actual
extent of activation due to combined activation and re-
pression; in the PvuII system, altering the repression-
associated C box leads to a huge increase in expression
[21]. These results indicate that the fusion is active as a
C protein.
BA
Figure 4 Test of CR fusion protein production. (A) The sequence
spanning the C-REase junction has properties that might result in
production of some free C protein. GCAAAAA has been associated
with −1 ribosomal frameshifts (see text for references), and this
would result here in termination at a nearby TGA triplet. (B)
Production of NsoJS138I C-REase fusion protein, with an amino-
terminal (upper) or carboxyl-terminal (lower) His6 tag, was induced
using a T7 RNA polymerase-dependent promoter (see Methods). The
upper panels show the results from clones having a small carboxyl-
terminal deletion (done in case the REase activity proved to be
toxic), while the lower panels show full-length clones. Centrifugally-
clarified whole-cell extracts were passed over affinity columns to
purify the His-tagged polypeptides, and resolved on duplicate 10-20
% gradient acrylamide SDS gels. For the lower panels, the extracts
were prepared in the presence of protease inhibitors. One gel of
each pair was stained (left), the other was electroblotted and probed
with anti-His-tag antiserum (see Methods). Loaded amounts of
protein per lane were 2.0 μg (upper), and 3.4, 6.8 and 5.1 μg (lower,
left to right).
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Three classes of RM systems that include R.PvuII
orthologs
In attempting to understand the evolution of regulation
in C-dependent RM systems, using PvuII as a model, we
searched for genes specifying proteins related to R.PvuII.
We and others have used this approach to assess the
genetic mobility of RM systems [28,47,48], but our pur-
pose here was to examine variation in regulatory mecha-
nisms. Searching for C protein orthologs of unusual size
might reveal more fusion proteins, but for our purposessuffers from two problems. First, as REases are highly
varied in sequence and structure [33-35], it would be dif-
ficult to be certain that the larger C-related proteins
were in fact C-REase fusions. Second, as we are inter-
ested in regulatory variation, requiring the presence of a
C protein would bias the search. In fact, we found three
classes of RM systems containing R.PvuII orthologs
(Figure 1A): classic PvuII-like systems with independent
C and REase proteins, C-REase fused systems such as
NsoJ138I, and systems lacking C proteins altogether. We
also demonstrated that the C-REase fusion of NsoJ138I
was active as both a REase and as a C protein.
Formation of C-REase fusions
The occurrence of active translational fusions between
REases and regulatory proteins has not previously been
reported, though automated annotations have indicated
the possibility. The standard genetic relationship be-
tween C and REase genes should facilitate fusion. Specif-
ically, in the great majority of C protein-dependent RM
systems, the C gene is upstream of and in the same
orientation as the REase gene; they often overlap (e.g.,
[49]). In the case of the PvuII-orthologous systems, we
expected the C-REase fusions to exhibit REase activity,
because R.PvuII tolerates synthetic fusions to yield an
active single-chain pseudo-homodimer [50], in which
one of the pseudo-monomers has the other fused to its
amino end; in addition, R.PvuII with an amino-terminal
fusion to maltose-binding protein is active [51]. With re-
spect to carboxyl-terminal fusions to C proteins, it is
noteworthy that a structural subclass of these proteins
has two additional helices (relative to C.PvuII) at its
carboxyl end [52]. We cannot rule out the possibility
that, in the native host (Niabella soli), some independent
expression of the two proteins occurs; however the im-
portant point here is that such separate expression is not
essential as the fusion protein exhibits both activities.
While C-REase fusions have not previously been char-
acterized, other types of REase fusions have. One class,
for example, involves natural and synthetic fusions of
the REase and MTase polypeptides [53-56]. This ability
to form a variety of active fusions illustrates the remark-
able flexibility and modularity of RM systems.
Implications of C-REase fusions
The fact that active C-REase fusions can and have
formed is intrinsically interesting for what it indicates
about the proteins involved. However an equally import-
ant question is what (if any) advantage might be
conferred by this arrangement. A key difference between
C-REase and MTase-REase fusions is that, in the case of
C and Type IIP REases, both proteins function as dimers
(Figure 6A). Thus MTase-REase fusions are expected to
dimerize via the REase portions to yield a dually-active
DCA
B
Figure 5 Assessment of C activity in CR.NsoJS138I. A. Schematic design of experiment. Top line indicates IPTG-inducible gene for T7 RNA
polymerase in the host strain’s chromosome, middle indicates a plasmid (pJL200, called pNso for the figure) that carries the gene for CR.
NsoJS138I linked to a T7 promoter, and the bottom indicates a plasmid (pJL300, called pBox-Lac for the figure) that carries the putative promoter
and C box region from NsoJS138I linked to a promoterless gene for lacZ (β-galactosidase). B. Sequence of the putative promoter and C box
region from NsoJS138I, showing the candidate C boxes (shaded) and promoter elements (−35 and −10 hexamers). This 161 nt sequence is what
was included in pJL300 (pBoxLac). C. Timecourse of LacZ induction. Growing triplicate cultures of cells containing the indicated plasmids were
treated at time = 0 with the inducer IPTG (which in these cells controls the gene for T7 RNA polymerase), and matched control cultures received
no IPTG. LacZ activity was measured over time. The symbols indicate means of the triplicate cultures; standard errors are shown but mostly
obscured by the symbols. D. Steady-state expression of lacZ. Triplicate cultures containing the plasmids indicated were grown for at least 10
generations in the presence or absence of IPTG, and LacZ activity was measured. In this case, activity is plotted vs. culture density, and so
modified Miller units are used (in which the culture density term has been removed). Cultures approximating steady-state growth should give
good linear fits, the slopes of which accurately measure relative expression levels. The symbols indicate means of the triplicate cultures; standard
errors are shown but are in some cases obscured by the symbols.
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sumably have to dimerize both the C and REase portions
to exhibit both activities. This could occur in three ways.
First, the C-associated and REase-associated dimerization
interfaces on one fusion polypeptide could both interact at
the same time with those on a second fusion molecule
(Figure 6B). Symmetry rules would make this dependent on
a linker region of sufficient length and flexibility. Looking at
the C-REase junction regions in Figure 2, it seems quite
unlikely that two molecules of Mru (CR.Mru1279I) or Nso
(CR.NsoJ138I) could dimerize both C and REase portions
at the same time; for the cyanobacterial fusions this seems
less unlikely due to the ~25 additional aa between the two
portions.
Second, the two interfaces could dimerize with two
different polypeptides, resulting in a concatameric chain
(Figure 6D). This second model is not mutually exclusive
with the first or third models. It is not clear what benefit
chain formation would have, but it is at least theoretic-
ally possible at higher protein concentrations, or if the
two interfaces have similar Kd values. For comparison,
however, the dimerization interface for R.PvuII is ~2300
Å2 [25,26], while that for a C protein (C.AhdI) is ~1400
Å2 [57].Third, and perhaps most interesting, is that the two
portions dimerize competitively (Figure 6C). That is, a
pair of fusion polypeptides can form either active REase
or active C protein at a given moment, but not both
simultaneously. If this competitive dimerization model is
true, the results would depend on the relative affinities
of the C and REase dimerization interfaces, and would
have implications for the relative timing of MTase and
REase appearance after the RM system genes enter a
new host cell. If the C interface were stronger, this
would minimize formation of substantial amounts of ac-
tive REase early, when low amounts of CR gene tran-
scription were occurring, but increase the sharpness of
the induction threshold. On the other hand, if the REase
interface were stronger than the C interface (as seems
likely given their relative interaction surface areas), there
would be early appearance of small amounts of REase
activity, but it would take longer for the positive feed-
back loop to cross the threshold for high expression of
the fusion gene, giving more time for protective methy-
lation to occur. Either way, this competitive dimerization
model seems to provide the most obvious (and testable)
hypotheses of the three interaction modes for possible
selective advantages of forming C-REase fusions.
AB
C
D
Figure 6 Possible interactions of C-REase fusion polypeptides. A. Unfused systems such as PvuII, where the C protein and REase form
separate homodimers. B. Fused system in which the linker between C and REase regions of the polypeptide is long enough and flexible enough
to allow simultaneous dimerization at both C and REase subunit interfaces. C. Fused system in which dimerization of the C portion is in
competition with dimerization of the REase portion. D. Fused system in which concatameric chains can form. See text for details.
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RM systems closely related to PvuII (as judged by simi-
larity of the REase sequences) have diverse regulatory
mechanisms. Most resemble PvuII in having a separate
regulatory (C) protein, but we found two that lack C
proteins and five in which the C and REase proteins are
fused. One of these fusion proteins, from the bacterium
Niabella soli, is active both as a REase and as a C pro-
tein. Fusions between C proteins and REases have not
previously been characterized. These results reinforce
the evidence for modularity among RM system proteins,
and raise important questions about the possible select-
ive advantages of C-REase fusion, including implications
of these fusions on RM system expression kinetics.
Methods
Strains and cloning
Using the RM system abbreviations listed in the legend
to Figure 1 (in alphabetical order), these are the
GenBank accession numbers for the DNA sequences:
Asp - AJWF01000012.1, Bce - ACCH01000218.1, Esp -
AEME01000001.1, Gsp - NC_020051.1, Lba - ACT
N01000006.1, Mru - NC_013946, Nso - NZ_AG
SA01000028, Oni - NC_019729.1, Pvu - AF305615.1,
Pwa - NC_013421.1, Sba - NT_033777.2, Spt -NC_011147.1, Ssp - NC_006511.1, Vei - NC_008786.1,
Xsp - AGHZ01000213.1. Initial searching used TBlastN
[36]. The Maximum Likelihood method, based on the
JTT matrix-based model [58] and with 1000 bootstrap
replications, was used to generate a phylogenetic tree
(Additional file 1: Figure S2). Evolutionary analyses were
conducted in MEGA [59].
The sequence containing the complete R-M system
of Niabella soli (1837nt, from GenBank accession #
NZ_AGSA01000028) was obtained from Genscript Inc.
(Piscataway, NJ). Some modifications were made to
optimize the distribution of restriction sites, but with-
out changing the specified amino acids. The inferred
NsoJS138I C-Box/promoter region (161nt) was also
obtained from Genscript, and for cloning purposes
XmaI and BamHI restriction sites were placed at the
ends. The truncated NsoJS138ICR was cloned into a
pACYCDuet-1 vector (Novagen®), with the N-terminus (C
protein end) in frame with the His-tag (using BamHI and
SaI I sites) and preceded by a T7 promoter, yielding pJL100
(“pNsoShort”). Full length NsoJS138ICR was cloned into
this vector, with the C-terminus (REase end) in frame with
the His-tag (using the NcoI site and yielding pJL200,
“pNso”), initially transforming a strain that already carried
the PvuII MTase gene. The synthesized NsoJS138I C-
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XmaI and ligated into pBH403, which is a derivative of
pKK232-8 and contains a promoterless lacZ gene
between two bidirectional transcription terminators
(Paul 2001), yielding pJL300 (“pBoxLac”). The primer
pair for making the truncated nsoJS138ICR PCR prod-
uct for pJL100 was 5′-cgtCCATGGacaaaagtcttatgccat
and 5′-cgtCCATGGatgaacgaaccaaatgctta, while the
primers for the full length product for pJL200 were 5′-
aatGTCGACttatttgggattattaatatccttatcac and 5′-aatGG
ATCCgatgaacgaaccaaatgc.
REase assays
To assess the enzymatic activity of CR.NsoJS138I, bac-
teriophage λ DNA (New England Biolabs, Ipswich MA)
was used as substrate. The related restriction enzyme
PvuII (New England Biolabs) was used for comparison.
Assays included 2.36 μg of partially-purified CR.
NsoJS138I-His6 (see below) or 10 u R.PvuII, with 1.5 μg
of λ DNA, and were incubated for 1 h. Temperatures
used were 27, 32, 37 and 42°C, in each of four standard
reaction buffers (New England Biolabs), and the DNA
was resolved on 0.8% agarose gels containing ethidium
bromide. pUC19 vector DNA (0.8 μg) was also used as
substrate to compare CR.NsoJS138I and R.PvuII. The
compositions of NEBuffers 1–4, respectively, are 10 mM
Bis-Tris-Propane-HCl, 10 mM MgCl2, 1 mM DTT (pH
7.0 at 25°C); 10 mM Tris–HCl, 10 mM MgCl2, 50 mM
NaCl, 1 mM DTT (pH 7.9 at 25°C); 50 mM Tris–HCl,
10 mM MgCl2, 100 mM NaCl, 1 mM DTT (pH 7.9 at
25°C); and 20 mM Tris-acetate, 10 mM magnesium
acetate, 50 mM potassium acetate, 1 mM DTT (pH 7.9
at 25°C).
Inducible expression and western blot analysis
Competent E. coli BL21(DE3) cells (Invitrogen, Carls-
bad CA), which have isopropythio-β-D-galactoside
(IPTG)-inducible T7 RNA polymerase expression,
were transformed with pJL100 or pJL200; some of
these transformants were made competent and further
transformed with pJL300. For protein purification, the
QIAexpress® protocol for His-tagged protein purifica-
tion was followed (QIAGEN, Germantown MD). Over-
night cultures were subcultured 1:20 into 250 mL of
LB medium at 37°C. IPTG was added to a final concen-
tration of 0.5 mM when the culture reached mid-log
phase (OD600nm ~0.46). Cells were grown for another
2.5 h before centrifugation and freezing pellets at −80°
C. The QIAexpress® Ni-NTA Fast Start Kit was used to
purify 6×His-tagged protein (under naïve condition).
The protease inhibitor phenyl-methyl-sulfonylfluoride
(PMSF, 0.5 mM) was added to the lysis buffer during the
purification of full-length CR.NsoJS138I. Column eluates
were immediately transferred into either Diluent B (NewEngland Biolabs recommended storage buffer for R.
PvuII; 300 mM NaCl, 10 mM Tris–HCl, 1 mM DTT,
0.1 mM EDTA, 500 μg/ml BSA, 50% Glycerol (pH
7.4@25°C)) or 2× SDS PAGE sample buffer (1:1 solu-
tion), and stored at −20°C. Protein concentration was
determined by the Pierce 660 nm Assay (Thermo
Scientific).
Purified proteins were separated by SDS-PAGE
(Novex® 10 ~ 20% Tris-Glycine gradient gel), and were
either stained with Coomassie blue or blotted onto
PVDF membranes at 30 V for 2 h using an Xcell appar-
atus (Invitrogen). For signal detection membranes were
blocked by incubation at 4°C overnight in 1% BSA-0.1%
Tween-20 in phosphate-buffered saline, followed by in-
cubation with a 1:1,000 dilution of mouse anti-His-tag
monoclonal antibody (EMD Millipore, Billerica MA) for
2 h at 4°C, followed by three 10-min washes. The blots
were then incubated for 2 h with 1:15,000 horseradish
peroxidase (HRP)-conjugated goat anti-mouse IgG
(Invitrogen) at room temperature. After three 10-min
washes, protein bands were visualized by ECL Plus en-
hanced chemiluminescence (GE Healthcare Biosciences,
Piscataway NJ) and image captured using an Alpha
Innotech FluorChem HD Imaging System using either
white light or dual 302/365 Å illumination. Adjustments
of brightness and contrast were carried out to better
visualize data, but in all cases the changes were applied
to the complete image. The pre-stained MW markers
used were SeeBluePlus (Invitrogen).
Assays for C protein activity
Plasmid pJL300 was used to transform E. coli BL21
(DE3) carrying pJL200 (plasmids described above). The
β-galactosidase (LacZ) assay was based on hydrolysis
of O-nitrophenyl-β-D-thiogalactoside (ONPG) [60].
Briefly, activity and culture density were measured at
20–30 min intervals during exponential growth. The
units for this assay were calculated by dividing the
measured A420nm (released nitrophenol) by the time
allowed for the reaction and volume of permeabilized
cells used for the reaction. For plots vs. time, culture
density (OD600nm) was also in the denominator, yielding
standard Miller units. For plots vs. culture density, this term
was omitted from the denominator, yielding modified
Miller units (1000 ×ΔA420nm min-1 ml-1). Specific activity
was obtained by determining the slope of a plot of LacZ
activity versus the culture density via linear regression.Additional file
Additional file 1: Figure S1. Alignment of R.PvuII orthologs. Figure S2.
Phylogenetic analysis of R.PvuII orthologs. Figure S3. Confirmation of
specific digestion conditions. Figure S4. Effect of enzyme dilution in
three reaction buffers. Figure S5. Test of CR fusion protein production.
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